Novartis unveils $23B US investment in manufacturing and R&D

Novartis is launching its latest investment initiative shortly after President Donald Trump introduced sweeping new tariffs on...

Natco to Sell Rare Spinal Disease Drug Risdiplam for Rs 15,900 Each

Natco Pharma announced that its generic Risdiplam will launch at Rs 15,900 per bottle, which might be a transformative moment for treating rare diseases in India. Roche's Evrysdi, marketed for spinal muscular atrophy (SMA) treatment, reaches Rs. 6.2

New Diabetes Drug Lowers Heart Complication Risk by 14%: Study

Novo Nordisk has made the complete SOUL results presentation today, the results from a 3-phase cardiovascular outcomes study indicated that oral semaglutide significantly decreased the risk of major adverse cardiovascular events in adults with...

UiPath and Google Cloud Collaborate to Transform Medical AI

Medical Record Summarization agent, powered by generative AI and launched by UiPath, a global leader in enterprise automation and AI software, at Google Cloud Next 2025, were developed by...

Biocon Biologics receives USFDA approval for cancer drug Jobevne

The USFDA has approved the cancer treatment medication Jobevne, which has allowed Biocon Biologics, the biosimilar division of Biocon, to increase its oncology portfolio.

Government introduces new regulations for imported medicines

In order to prevent the sales of unapproved or illegal medicines in Indian market, import registration and license have been made mandatory by The Central Drugs Standard Control Organization. On April 8, the apex drug regulatory agency of India...

Trump Announces Upcoming Major Tariff on Pharmaceutical Imports

The United States president Donald Trump announced that the U.S will shortly introduce a "major" tariff on pharmaceutical imports. “We are going to be announcing very shortly a major tariff on

Obesity Drugs Gain Momentum in India as Market Grows Over Fourfold

The anti-obesity drug market in India experienced a remarkable fourfold increase from March 2021 to March 2025 according to PharmaTrac data with a value growth from ?133 crore to ?576 crore. The market points to lifestyle disorders as well as consume

Cadila Pharma Launches Vasograin EC with FDA-Approved Migraine Formula

The well-known migraine drug Vasograin has a new formulation called Vasograin EC, which was announced by Cadila Pharmaceuticals. The updated formulation is currently manufactured in a US FDA-approved facility that complies with global quality and....

UniSA Researchers Develop Quantum-Powered Laparoscopic Probe for GI Cancers

Researchers at the University of South Australia (UniSA) are working on a laparoscopic probe that uses quantum technology to enhance the detection of gastrointestinal cancers. Supported by the federal government's Economic Accelerator...

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.